| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000031620 |
| Receipt No. | R000035975 |
| Scientific Title | A randomized controlled trial of telecare and face to face consultation with CA-F17 based on the standard smoking cessation program for nicotine dependence. |
| Date of disclosure of the study information | 2018/03/08 |
| Last modified on | 2019/09/03 (Ver. 5) |
| Basic information | ||
| Public title | A randomized controlled trial of telecare and face to face consultation with CA-F17 based on the standard smoking cessation program for nicotine dependence. | |
| Acronym | A randomized controlled trial of telecare and face to face consultation with CA-F17 based on the standard smoking cessation program for nicotine dependence. | |
| Scientific Title | A randomized controlled trial of telecare and face to face consultation with CA-F17 based on the standard smoking cessation program for nicotine dependence. | |
| Scientific Title:Acronym | A randomized controlled trial of telecare and face to face consultation with CA-F17 based on the standard smoking cessation program for nicotine dependence. | |
| Region |
|
|
| Condition | |||
| Condition | nicotine dependence | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Randomized, controlled non-inferiority study to assess the efficacy and safety of CA-F17 using telecommunications technology in addition to the standard smoking cessation treatment program as compared with face to face consultation. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 9-12 week Continuous Abstinence Rate |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Intervention group:One-time dispense of CA-F17 in conjunction with 3months of Standard Treatment of Nicotine Dependence using telecommunications technology.
|
||
| Interventions/Control_2 | Control group:One-time dispense of CA-F17 in conjunction with 3 months of Standard Treatment of Nicotine Dependence with face to face consultation. | ||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Cases using a smartphone, diagnosed as nicotine dependent on tobacco dependence screening test who intend to quit smoking immediately | |||
| Key exclusion criteria | Cases judged difficult to participate in the trial, such as severe mental illness | |||
| Target sample size | 114 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kanazawa University Hospital | ||||||
| Division name | Innovative Research Center | ||||||
| Zip code | 9200934 | ||||||
| Address | 13-1,Takaramachi, Kanazawa city, Ishikawa prefecture | ||||||
| TEL | 076-265-2049 | ||||||
| anomura@med.kanazawa-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | CureApp, Inc. | ||||||
| Division name | Clinical and Regulatory Affairs Department | ||||||
| Zip code | 1030001 | ||||||
| Address | 12-5, Kodenmacho, Nihombashi, Chu-o-ku, Tokyo | ||||||
| TEL | 03-6231-0183 | ||||||
| Homepage URL | |||||||
| clinreg_admin@cureapp.jp | |||||||
| Sponsor | |
| Institute | CureApp, Inc. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | CureApp, Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Tokyo-Eki Center-building Clinic Institutional Review Board |
| Address | 3-3-14, Nihombashi, Chuo-ku, Tokyo, 103-0027, Japan |
| Tel | 03-1526-6688 |
| info_tecc-irb@clinipro.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://www.researchprotocols.org/2019/7/e12701/ |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | https://www.jmir.org/2019/4/e13520/ | ||||||
| Number of participants that the trial has enrolled | 115 | ||||||
| Results | We randomized 115 participants with nicotine dependence: 58 were allocated to the telemedicine (internet-based video counseling) arm and 57, to the control (standard face-to-face clinical visit) arm. We analyzed all 115 participants for the primary outcome. Both telemedicine and control groups had similar CARs from weeks 9 to 12 (81.0% vs 78.9%; absolute difference, 2.1%; 95% CI -12.8 to 17.0), and the lower limit of the difference between groups (-12.8%) was greater than the prespecified limit (-15%). |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results |
|
||||||
| Baseline Characteristics | |||||||
| Participant flow | |||||||
| Adverse events | |||||||
| Outcome measures | |||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035975 |